Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...

Could the largest market for the new schizophrenia drug xanomeline and trospium chloride (Cobenfy) be in Alzheimer's disease ...

The global schizophrenia drugs market size was valued at USD 7.88 billion in 2024 and is projected to reach from USD 8.28 ...

Although serious mental illness has a genetic component, developing these four protective factors can help you take control ...

The trial of a rural Franklin woman who claimed she is God and the man she killed is Satan concluded Thursday.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The father of a man who went on a fatal stabbing rampage in Sydney’s Westfield Bondi Junction mall last year says his dead ...

Psychiatric disorders often overlap and can make diagnosis difficult. Depression and anxiety, for example, can coexist and ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

There are now some 300 published peer-reviewed studies on the efficacy of BrainHQ , including 96 studies in healthy older adults, 4 studies in workplace performance, and 200 studies across a wide ...

SANE is alarmed but not surprised to see mass resignation of psychiatrists in NSWThe resignation of public sector psychiatrists in NSW is a serious ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...